Author: FWA

Clinical Context Prediabetes affects approximately 96 million American adults, with global prevalence estimates exceeding 500 million. The condition represents a crucial intervention window: the Diabetes Prevention Program (DPP) demonstrated that intensive lifestyle intervention reduces progression to type 2 diabetes by 58%. However, the original DPP model required 16 in-person sessions over 24 weeks plus monthly follow-up—a resource-intensive approach difficult to scale in primary care. Digital health interventions offer the promise of scalability. Text messaging (SMS) is particularly attractive because it requires no app downloads, works on basic phones, and has near-universal reach. SMS-based programs have shown efficacy for medication adherence,…

Read More

Clinical Context Chronic low-grade inflammation is increasingly recognized as a key driver of metabolic disease. In obesity and prediabetes, adipose tissue becomes dysfunctional, secreting pro-inflammatory cytokines (TNF-α, IL-6) while infiltrating macrophages perpetuate inflammation. This inflammatory milieu contributes to insulin resistance, beta-cell dysfunction, and ultimately type 2 diabetes. Elevated CRP and other inflammatory markers predict diabetes development independent of glycemia. Weight loss improves inflammation, but questions remain about whether the method of weight loss matters. Intermittent fasting (IF) and time-restricted eating (TRE) have gained popular attention, with proponents claiming benefits beyond simple calorie reduction—purportedly through effects on circadian biology, autophagy, and…

Read More

Clinical Context Chronic low-grade inflammation is increasingly recognized as a central driver of metabolic disease progression. In obesity and prediabetes, dysfunctional adipose tissue becomes a source of pro-inflammatory cytokines (TNF-α, IL-6, MCP-1), while infiltrating macrophages perpetuate local and systemic inflammation. This inflammatory state contributes to insulin resistance, accelerates beta-cell dysfunction, and promotes atherosclerosis—creating a pathophysiological environment primed for type 2 diabetes and cardiovascular disease. Weight loss consistently reduces inflammatory markers, but whether different weight loss methods have differential effects on inflammation remains debated. Intermittent fasting (IF) and time-restricted eating (TRE) have gained substantial popularity, with proponents suggesting metabolic benefits beyond…

Read More

Clinical Context Cognitive decline and dementia represent enormous public health challenges, with limited effective treatments available. The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) was specifically designed to protect brain health by combining elements of the Mediterranean and DASH diets with additional emphasis on foods associated with reduced dementia risk in observational studies—particularly green leafy vegetables, berries, nuts, and fish while limiting red meat, butter, cheese, pastries, and fried foods. Obesity is an established risk factor for cognitive decline, with mechanisms including inflammation, insulin resistance, cerebrovascular disease, and altered brain structure. The intersection of obesity and cognitive health suggests that…

Read More

Clinical Context Pediatric type 1 diabetes management is notoriously difficult, with most children and adolescents failing to achieve glycemic targets. Mean HbA1c levels in pediatric populations typically exceed 8%, well above the <7% target recommended for adults and the <7.5% target suggested for youth. The challenges are multifactorial: developmental changes in insulin sensitivity, unpredictable eating and activity patterns, psychological factors including diabetes distress and burnout, and the inherent complexity of replicating physiological insulin secretion with exogenous injections. Continuous glucose monitoring (CGM) has transformed diabetes care by providing real-time glucose data and trend information. However, CGM alone doesn’t improve outcomes—it’s what…

Read More

Clinical Context Diabetic foot ulcers (DFUs) remain a devastating complication in low- and middle-income countries, where limited access to specialized care and delayed presentation lead to high amputation rates. In India, an estimated 40,000 leg amputations occur annually due to diabetes, many preventable through basic foot care education. Prevention is far more effective than treatment: daily foot inspection, proper footwear, prompt attention to injuries, and regular professional foot examinations can dramatically reduce ulcer incidence. However, knowledge alone is insufficient. Many patients know what they should do but fail to maintain consistent foot care practices. The gap between knowledge and behavior…

Read More

Clinical Context Diabetic foot ulcers (DFUs) represent one of the most devastating and preventable complications of diabetes. In India, where diabetes prevalence has reached epidemic proportions, an estimated 40,000 leg amputations occur annually due to diabetes—many preventable through basic foot care education and early intervention. The economic burden of diabetic foot disease in low- and middle-income countries (LMICs) is catastrophic for families, often pushing households into poverty through lost income and healthcare costs. Prevention through education is far more effective than treatment of established ulcers. Daily foot inspection, proper footwear, hygiene practices, and prompt attention to minor injuries can dramatically…

Read More

Clinical Context Diabetic peripheral neuropathy affects up to 50% of patients with diabetes, and painful diabetic neuropathy (PDN) develops in 20-30% of those affected. The pain is characteristically described as burning, shooting, or stabbing, often worse at night and significantly impairing sleep and quality of life. Current pharmacological treatments—pregabalin, duloxetine, gabapentin, and tricyclic antidepressants—provide meaningful relief for only 30-50% of patients, and side effects (sedation, weight gain, cognitive impairment) limit tolerability. This unmet need drives interest in non-pharmacological approaches. Non-invasive peripheral nerve radiofrequency (NipRF) neuromodulation delivers energy transcutaneously, potentially providing benefits similar to implantable devices without invasive procedures. PICO Summary…

Read More

Summary: In patients with type 2 diabetes using a general diabetes self-management mHealth app (Diabetes Plus), use of the Diabetes Plus app including dietary self-monitoring and basic nutritional feedback resulted in consumption of less than the recommended 20 g/day of dietary fiber on average over one year compared to general dietary recommendations for fiber intake, though it was associated with no reported serious adverse effects; underscoring the need for alternative mHealth strategies to improve dietary fiber intake. PICO Description Population Adults with type 2 diabetes mellitus engaging in self-management using the DiabetesPlus mHealth application. Intervention Utilization of the DiabetesPlus app…

Read More

Summary: In Asian Indian adults with type 2 diabetes, Fenuflakes TM supplementation significantly reduced 24-hour glycemic variability and improved glycemic control compared to usual dietary practices without FenuflakesTM, though it was associated with no major reported adverse side effects. PICO Description Population Asian Indian adults diagnosed with type 2 diabetes. Intervention Dietary supplementation with FenuflakesTM incorporated into regular diet. Comparison Usual dietary habits without FenuflakesTM supplementation. Outcome FenuflakesTM significantly reduced 24-hour glycemic variability and improved overall glycemic control, as measured by continuous glucose monitoring. No significant adverse side effects were reported. Source: Pallavi Onkar Deshpande, et al. “Effect of FenuflakesTM…

Read More